false
OasisLMS
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Login
Catalog
SCAI 2026 Sirolimus-Eluting Balloons in Coronary P ...
Review of SELUTION DeNovo Trial, Dr. Ladwiniec
Review of SELUTION DeNovo Trial, Dr. Ladwiniec
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discusses a de novo calculation and advances in drug-coated balloon (DCB) and sirolimus-coated balloon technology, noting some progress has been retracted. They emphasize concerns about protocol adherence, stenting versus balloon treatment, and how misclassification affected trial group assignments. The talk highlights learning effects in early cases, suggesting outcomes improved as operators gained experience. The speaker also notes that procedural effort and complexity can vary without necessarily changing clinical results, and that operator performance may have improved by over 30% in some analyses.
Asset Caption
closed captions are computer-generated
Keywords
de novo calculation
drug-coated balloon
sirolimus-coated balloon
protocol adherence
operator learning curve
×
Please select your language
1
English